skip to Main Content


Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."


United Healthcare Home Immunotherapy Policy Change

United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer…

Read more

Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

12/01/23: Research Grant Cycle
Learn more

04/01/24: Fellow Exam Application Deadline
Learn more


2023 AAOA Basic Course

Register Now to access over 26 hrs of CME | Continuing Certification through our 2023 Hybrid Basic Course in Allergy & Immunology.  Launching with core pre-work on demand June 1, the live component will build on the basics of adding allergy, including hands-on practica.  Post course, registrants have access to all the content until September 1, 2023. Learn More


For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More


Available Now


IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2023 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Access to over 19 hrs of CME | Continuing Certification until June 1
Learn More and Register

2023 AAOA Basic Course in Allergy & Immunology - Hybrid
June 1 - Pre-Work On-Demand
June 29 – July 1 - Live
September 1 - Access
Hyatt Regency Seattle
Learn More and Register

2023 AAOA Annual Meeting - Hybrid
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - November 1, 2023

News and Updates

American Elm Shortage

American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices…

Read more

USP General Chapter Released

After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of…

Read more
College Allergy Symptoms Treatment Back to Shcool


AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More


AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>


How Does One Test for Allergies?

By Jodi Zuckerman MD, FAAOA

Allergy testing can be used to confirm that specific antigen triggers (grass, ragweed, dust mite, cat) produce a body response that triggers a histamine release and allergy cascade. Identifying these triggers can be helpful in treatment options of avoidance, medical management, and  immunotherapy. 

There are two main ways to test for allergies.  Both are measuring the response of the body to an allergen presentation.  The first possible way is through skin testing.  There are different methods of skin testing.  In skin prick testing, an antigen is presented to the skin with a small prick device at a very superficial level.  A response is measured by a resultant wheel that indicates how reactive or allergic you are to that allergen after waiting an allocated amount of time. 

The other form of skin testing is with a needle presenting the antigen to a deeper layer of skin.  This is called intradermal testing.  The response is also measured by the size of the wheel after presentation to the dermis of the skin.  Skin prick and intradermal testing can be used alone or in a combined fashion known as the modified quantitative testing where the response by skin prick will determine the concentration of antigen used to be applied to the dermis of the skin and this resultant reactivity is used as a safe endpoint of concentration of antigen for further immunotherapy. 

There are certain situations in which skin testing cannot be performed. Patients may be on medications that inhibit the response like tricyclic antidepressants, antihistamines, or medications that could interfere with emergency response of a severe reaction such as Beta-Blockers.  Skin disorders such as dermatographism and glycerine sensitivity may also require alternative testing. 

Allergy response can also be measured by a blood test looking specifically for antibodies that have been made in the blood that play a role in the allergic response when the specific allergen is encountered. This is commonly referred to as RAST (Radioallergoabsorbant Testing) and looks for the number of IgE antibiodies in the blood for a presumed antigen.  

Once the physician is able to review the results of the testing a guided treatment plan can be devised.  A positive test is not always significant and is taken in consideration with elements of the patient’s symptoms such as seasonality, exposures, and severity of symptoms.

Back To Top